], Swi1 ring/ribbon-like aggregates predominantly colocalize with the Sup35 or Rnq1 aggregates; without a preexisting prion, however, such colocalizations are rarely seen during Swi1-PrD overproduction-promoted Swi1 prionogenesis. We have thus demonstrated a complex interacting mechanism of yeast prionogenesis.
1
] prionogenesis remain poorly understood. In this study, we have constructed floccullin-promoter-based URA3 reporters for [ 
Introduction
Prions, proteinaceous infectious particles, are composed of host proteins with altered and transmissible conformations (Colby and Prusiner, 2011; Wickner et al., 2015) . Although the term prion was first used to describe the causative agent of the neurodegenerative diseases known as transmissible spongiform encephalopathies (TSEs) (Prusiner, 1982; Prusiner, 1998) , this proteinonly prion concept has been expanded to include a large number of fungal and mammalian proteins that can also undergo conformational changes and be transmitted as highly-ordered aggregates termed amyloids (Crow and Li, 2011; Munch et al., 2011; Luk et al., 2012; Sanders et al., 2014) . In the budding yeast Saccharomyces cerevisiae, at least nine prion proteins have been identified and additional potential prions may exist (Crow and Li, 2011; Suzuki et al., 2012; Halfmann et al., 2012; Chakrabortee et al., 2016) . When these prion proteins adopt prion conformation(s), the resulting prions usually manifest as dominant and heritable features, mostly through modulation of important cellular processes such as transcription and translation (Serio and Lindquist, 1999; Alberti et al., 2009; Stein and True, 2014; Du et al., 2015) . In addition, it has been shown that some yeast prions can exist in wild strains and their prion conformational switches can be environmentally responsive, suggesting a possible role of prionogenesis in yeast adaptation to environmental fluctuations (Tyedmers et al., 2008; Suzuki et al., 2012; Holmes et al., 2013; Jarosz et al., 2014) . Interestingly, protein misfolding, aggregation, and subsequent amyloid deposition have been proposed to be crucial etiological events associated with more than 40 incurable mammalian disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS) and recently, cancers (Munch et al., 2011; Ano Bom et al., 2012; Luk et al., 2012; Sanders et al., 2014) . Yeast prions have become valuable systems for studying prion biology and other proteinopathies due to sharing similar structural features and transmission mechanisms with PrP 2001)), b-amyloid (peptides of 36-43 amino acids derived from a protein known as amyloid protein precursor and implicated in Alzheimer's disease (Vassar et al., 1999) ), and a-synuclein (an abundant protein in the brain implicated in a group of disorders known as synucleinopathies when it becomes insoluble (Spillantini et al., 1997) ). Utilizing yeast prion systems, important knowledge has been gained regarding molecular mechanisms of prion formation and transmission and important cellular factors required for prionogenesis, such as molecular chaperones -Hsp104, Hsp40 and Hsp70 and its co-chaperones -have been identified (see reviews of (Guinan and Jones, 2009; Romanova and Chernoff, 2009; Winkler et al., 2012; Sporn and Hines, 2015) ). In addition, valuable information regarding how heterologous prion proteins interact with each other and how such interactions influence their de novo prion formation and maintenance has also been reported (Derkatch et al., 1997; Derkatch et al., 2001; Osherovich and Weissman, 2001; Schwimmer and Masison, 2002; .
Perhaps the most studied yeast prion is [
whose protein determinant is Sup35, a translational termination factor (Stansfield et al., 1995) . When Sup35 enters a prion conformation, it results in a compromised translation termination function (Patino et al., 1996) . Previously, it was reported that overproduction of Swi1, a subunit of the SWI/SNF chromatin-remodeling com- ] exhibit a partial loss-of-function phenotype of SWI/SNF (Du et al., 2008) . We also showed that preexisting [SWI 1 ] can promote the de novo formation of [PSI 1 ] and another prion known as [PIN 1 ] or [RNQ 1 ], whose protein determinant is Rnq1 (Derkatch et al., 1997; Sondheimer and Lindquist, 2000; ] promotion by [SWI 1 ] is likely realized mainly through a cross-seeding mechanism. The cross-seeding model proposes that a preexisting prion can provide a conformational template on which seeds of a different prion can form . In this case, the Swi1 prion aggregates could recruit Rnq1 or Sup35 to form ring/ribbon/rod-like (ring/ribbon-like hereafter) heterogeneous aggregates in [SWI 1 ] cells that are prionogenic, i.e. capable of leading to the formation of [PINQ 1 ] or [PSI 1 ] ( . In addition, we also reported an antagonizing effect between [ (Mao et al., 2008) . Flocculins or adhesins are a group of lectin-like cell wall proteins that confer a variety of multicellular features in several Candida albicans and S. cerevisiae strains (Li and Palecek, 2005; Barrales et al., 2008; Barrales et al., 2012 
Results
Constructing URA3-based [SWI 1 ] reporters using FLO gene promoters
The yeast S288C strain has two active flocculins, Flo1 and Flo11, which are encoded by two FLO genes, FLO1 and FLO11, respectively, and whose functions are essential for exhibiting the multicellular phenotypes of this strain (Kobayashi et al., 1999) . Due to containing an internal in-frame stop at codon 142 in the FLO8 gene, S288C-derived strains do not express FLO1 or FLO11 and thus cannot exhibit multicellular phenotypes . Flo8 is a key transcriptional activator in the cyclic adenosine monophosphate-dependent protein kinase A (cAMP-PKA) pathway and it acts in concert with other activators such as Mga1 and Mss11 in activating FLO promoters (Bester et al., 2006; Kim et al., 2014; Mayhew and Mitra, 2014) . Upon repair of FLO8, the expression of FLO1 and FLO11 can be activated and multicellular phenotypes can be restored, such as flocculation and adhesive growth of haploid cells, as well as pseudohyphal growth of diploid cells (Fichtner et al., 2007) ] using the FLO promoters. Since the FLO1 promoter contains multiple reported interaction sites for SWI/SNF which can be > 5 kb upstream of the FLO1 start codon (Fleming and Pennings, 2001 ), it is difficult to clone or engineer the FLO1 promoter for this purpose. We thus focused on the FLO11 promoter in this study. As shown in Fig. 1A , the FLO11 promoter contains multiple defined upstream activation sequences (UASs) and upstream repression sequences (URSs), which span a region of about 2.8 kb before the translation start codon (Rupp et al., 1999) . Although published data showed that these UASs within the FLO11 promoter could respond independently to diverse external and internal signals, determination of the SWI/SNF-acting UASs was reported to be difficult (Rupp et al., 1999; Braus et al., 2003; Basu et al., 2004) . Since Swi1 is required to activate FLO11 gene expression (Basu et al., 2004; Du et al., 2015) , we assumed that the SWI/SNF (thus, Swi1)-acting sites are within the previously identified UASs but not URSs. To identify Swi1-acting sites, we generated six truncated FLO11 upstream regulatory region containing various numbers of UASs (1) and/or URSs (-) by PCR ( Fig. 1A and Supporting Information Fig. S1 ), and cloned them into the upstream of URA3 ORF in a p415-based plasmid harboring a CYC1 terminator. In these transcriptional fusion constructs, 50-bp of left and right sequences corresponding to the upstream and downstream regions of the LYS2 ORF are included to flank the expression cassette, which can be used for integrating the reporter into the LYS2 locus (Fig. 1B) .
To test if these reporter plasmids can be used for [SWI 1 ] study, we first compared their URA3 expression in wild-type, single, and double mutant strains of flo8 and swi1D (Fig. 1C ). Except for P F16 , a 1.2 kb fragment from the 5'-site of the FLO11 start codon containing 4 UASs and 2 URSs, all tested truncations supported cell growth on media without uracil for the wild-type strain (FLO8/SWI1), suggesting that the two URSs at the region of 2600 to 21000 bp confer a strong repression. Considering P F19 behaved similarly to the wild-type FLO11 promoter (P FLO11 ), the 2000-bp upstream sequence of FLO11 seems to contain most of the critical regulatory elements in S288C strains. The fact that P F19 and the wild-type FLO11 were the only two inactive promoters in flo8 or swi1D mutant strain suggests that their de-repression requires both functions of Flo8 and Swi1. The activity of P F13 was slightly reduced in swi1D but not in the flo8 strain, suggesting that Swi1 but not Flo8 plays a major activator role in interacting with the UASs between 21 and 2600 bp. It was previously reported that that P F13 may serve as a core promoter containing the basal regulatory sites (Braus et al., 2003) . Indeed, the activities of P F136 , P F139 and P F1369 , which contain one or two more activator binding sites beyond P F13 , exhibited no significant enhancement of activity comparing to that of P F13 in the wild-type strain (Fig. 1C) . Based on the activities of P F16 and P F19 , one may speculate that the region of 21600 and 22000 must contain UASs that interact with both Swi1 and Flo8 to de-repress the URSs between 2600 and 21000 as P F16 grew poorly in SC-ura in all strain backgrounds, however, P F19 grew well in the wild-type strain, but not in any of the mutant strains (Fig. 1C) . Importantly, promoters other than P F19 and P FLO11 showed significant activities in single mutant strains (Fig. 1C) , suggesting that Flo8 and Swi1 likely have redundant functions in activating some of the truncated FLO11 promoters. Taken together, these results demonstrate a complex regulation of FLO11 promoter by SWI/SNF and Flo8, particularly of the Swi1 responding cis-elements of the promoter.
We next examined if plasmids built with the aforementioned truncated FLO11 promoters and three additional SWI/SNF-regulated promoters, SL (a chimeric SUC2-Leu2 promoter) (Neigeborn and Carlson, 1987) , Alcohol DeHydrogenase II (ADH2) (Biddick et al., 2008) , and HOmothallic switching endonuclease (HO) (Stern et al., 1984) in the -uracil assay in the presence of FLO8 but not in the 15-FOA assay in either flo8 or FLO8 background (Supporting Information Fig. S3 ). As we showed previously (Du et al., 2015) ] reporters in 74D-694 strain and derivatives, which are commonly used for yeast prion studies. Upon examination, we found that the 74D-694 strain does not display multicellular phenotypes (data not shown), suggesting that the FLO genes are not expressed. DNA sequencing data demonstrated that the FLO8 gene contains a point mutation in the code of the 142th amino acid (tryptophan) to a stop code, which is identical to that in S288C strain ( Fig. 2A) . Thus, the lack of multicellularity of 74D-694 is due to the same flo8 mutation of S288C. We transformed a plasmid expressing FLO8 into a wild-type 74D-694 strain and tested if FLO8 expression could restore the multicellular features, and if so, would these phenotypes be regulated by [SWI 1 ]. We found that ectopic expression of FLO8 driven by its own promoter from a CEN-plasmid successfully restored the multicellular phenotypes of adhesive growth (Fig. 2B) and flocculation (Fig. 2C) Figs 1D and 2E ). However, P F19 -URA3 can be used in either -uracil or 15-FOA assay for both S288C and 74D-694 strains only when Flo8 is ectopically expressed. These results demonstrate strain-specific performance of the two reporters. ] reporters for S288C strains. A. A diagrammatic illustration of the wild-type and truncation mutant FLO11 promoters. The 3-kb FLO11 promoter (P FLO11 ) spans 15 0.2-kb segments carrying 7 upstream repression sequences (URSs, -) and 5 upstream activation sequences (UASs, 1). The dotted lines stand for regions that are deleted. Construction strategies are shown in Supporting Information Fig. S1 . B. A diagram showing the structure of constructed reporter plasmids. URA3 gene serves as a reporter gene driven the wild type or a truncated FLO11 promoter shown in A. CYC1 terminator was included for all the constructs. 50-bp upstream and downstream extensions of LYS2 flank the reporter to provide an option to integrate a reporter into chromosome. C. BY4741 non-prion strains with the indicated genotypes were transformed with individual p415-based URA3 reporter plasmids. Cells were spotted onto synthetic complete (SC) selective plates without uracil. Images were taken 3 days post spotting. Shown is a representative result of at least three independent experiments. D. The indicated FLO8 or flo8 strains with distinct Swi1 prion status were transformed with either P F139 -URA3 or P F19 -URA3 plasmid and assayed for growth on glucose-containing SC medium (glucose) without uracil (-uracil), or with 5-FOA (15FOA). Raffinose plate (glucose-free) was also included to verify the Swi1 status. Shown are representative results (3 days post-spotting) of at least three repeated tests. The maintenance of a yeast prion requires a concerted action of multiple molecular chaperones and other cellular factors (Winkler et al., 2012; Masison and Reidy, 2015) . It was reported earlier that Sse1 overproduction can eliminate [SWI 1 ] in 74D-694 strain whereas Hsp104 overproduction cannot (Du et al., 2008; . To validate the suitability of the plasmid-based ] S288C strains containing the P F139 -URA3 plasmid were treated with 5-mM GdnHCl, the reporter plasmid was effective in detecting the [SWI 1 ] curing as demonstrated by a lack of growth in 15-FOA media for both flo8 and FLO8 strains (Fig. 3A) . The 1.0 mg/mL 5-FOA concentration showed clear delineation between the prion and cured conditions and was used in the rest of the experiments described in this article. Experiments were conducted using the P F139 -URA3 reporter plasmid in both 74D-694 and BY4741 (S288C derivative) strains. Fig. S3 and Fig. 1D ). The 5-FOA resistant (5-FOA 1 ) colonies were screened and then examined for their curability by 5 mM GdnHCl ( Fig. 4A and data not shown). ] reporters for 74D-694 derivatives. A. DNA sequencing data demonstrate that the 74D-694 strain contains the same nonsense mutation in the FLO8 ORF as S288C-derivated strains. B. Plasmid p413FLO8 was introduced into the four indicated strains to ectopically express Flo8 under its own promoter. Transformants were then tested for adhesion on SC selective plates using a wash assay (see Experimental Procedures). The remaining cells were imaged prior to and after washing (a representative result of at least three repeated assays). C. The same strains used in panel B were assayed for flocculation (cell-cell adhesion, or cell aggregation, see details in Experimental Procedures). 0 min, immediately after vortexing the cell cultures; 15 min, 15 min after keeping cultures still on bench post-vortex. Shown is a typical result of at least three repeated tests. D. Indicated isogenic 74D-694 strains were examined for raffinose phenotype (right) and aggregation patterns of Swi1NQYFP (NQ), Sup35NMGFP (NM) and Rnq1GFP (RNQ1) after transforming them with p416TEF-NQYFP, pCUP1-NMGFP, or pCUP1-RNQ1GFP. E. Indicated strains were co-transformed with p415F139-URA3 and p413FLO8 or p413TEF (vector), and assayed for their growth on glucosecontaining SC medium (glucose) without uracil (-uracil), or with 5-FOA (15FOA). Shown are representative results (3 days post-spotting) of at least three repeated assays. F. Experiment was carried out similar to that in panel E except that p415F19-URA3 was used instead of p415F139-URA3. ] strains were transformed with p415F139-URA3, and streaked on SC selective plates (SC) with (1) or without (-) 5 mM GdnHCl and then cultured in SC-leu which was followed by growth on the indicated SC selective plates. Shown was a result (3 days post-spotting) of at least 3 independent experiments. B-D. As described in the Experimental Procedures, the influences of Hsp104 overproduction (HSP104), Hsp104 inactivation (GdnHCl), and Sse1 overproduction (SSE1) on [SWI 1 ] propagation in 74D-694 (B) and BY4741 (C and D) backgrounds were investigated. vector, an empty vector control; SC, SC selective plate; 5FOA, SC selective plate with 5-FOA; Raf, raffinose plate; n, total colonies assayed. Note: the plasmid reporter P F139 -URA3 was used for panel B and C, but chromosomal reporter of P FLO1 -URA3 for panel D. Prion curing was summarized in the plot (right panel) based on the growth phenotypes (left). E. Effect of Sse1 or Hsp104 overproduction on [SWI 1 ] curing by GdnHCl was assayed as described in the Experimental Procedures. The remaining [SWI 1 ] was assayed after growing cells in SC 1 GdnHCl medium for the indicated time while overproducing Hsp104 or Sse1. T-test was used to estimate the significance of the differences (N.S., not significant; **, P < 0.01; ***, P < 0.001). n, colonies assayed.
Establishing and analyzing a reliable [SWI
Candidates that were able to convert from Ura -5-FOA Fig. S4 and data not shown) . Thus, 0.02% galactose serves as minimal concentrations to show [SWI 1 ]-specific Swi1N or NQYFP aggregation (Supporting Information Fig. S4 ). Isolates with NQYFP aggregation were further colony-purified and reassayed for aggregation stability, growth phenotypes on -uracil, 15-FOA, and raffinose plates, and curability by 5 mM GdnHCl (Fig. 4C and data not shown).
As shown in Fig. 4B ] strains than that in the non-prion strain respectively (Fig. 4B) (Fig. 5A ).
Interacting mechanisms in spontaneous and pre-existing prion-induced [SWI 1 ] initiation
Protein misfolding and aggregation are critical events that lead to prionogenesis (Landreh et al., 2016) . Upon overproduction prionogenic aggregations of Sup35 and Rnq1 often occur and appear to be ring/ribbon-shaped , and non-prion, were co-transformed with p423GAL1-NmCherry and pCUP1-NMGFP (green bars), or with p423GAL1-NmCherry and pCUP1-RNQ1GFP (orange bars). SC-leu-ura sucrose cultures of the transformants were supplemented with 0.02% (B) or 0.5% (C) galactose and 10 lM CuSO 4 . After incubation for 48 h, percentages of cells with all types of aggregation (total aggregation) or ring/ribbon-like only aggregation of Swi1N-mCherry are shown. Statistical analysis for panel A-C was performed by T test (N.S, not significant; **, P < 0.01; ***, P < 0.001). (Zhou et al., 2001; Mathur et al., 2010; . Ring/ribbon-like aggregation was also seen for other prion and prion-like proteins [18] . As shown in Fig. 4C ] isolates (Fig. 5A) by the percent frequency of cells with with ring/ribbon-like aggregates ( Fig. 5B and C) ]. As expected, Swi1-PrD overproduction (0.5% galactose) promoted the total and ring/ribbon-like aggregation of N-mCherry (compare Fig. 5B and C) . Importantly, Swi1-PrD overproduction-induced N-mCherry aggregation is predominantly ring/ribbon-like (Fig. 5C) , which was consistent with the capacity of Swi1-PrD in promoting [SWI 1 ] formation (Fig. 5A) . Although the dominance of ring/ribbon-like aggregation is relatively low under overproduction conditions compared to that under nonoverproduction (compare Fig. 5B and C ] than the non-prion control with Swi1-PrD overproduction though the two strains showed similar amount of ring/ribbon-like aggregation of N-mCherry ( Fig. 5A and C ], or an event of Swi1-PrD overproduction, is achieved by facilitating Swi1 aggregation, including the ring/ribbon-like aggregation.
In the same experiments, we assayed the interaction of Swi1N-mCherry ring/ribbon-like aggregates with Sup35NMGFP and Rnq1GFP under non-overproduction conditions and observed both colocalization (crossseeding) and non-colocalization patterns for all tested strains (Fig. 6A and B ] cells, respectively, in which the two preexisting prion aggregates were morphologically remodeled from dot-shaped Establishing and analyzing a reliable [SWI to ring/ribbon/rod-like. Similarly, about 63% and 59% of Swi1N-mCherry ring/ribbon-like aggregates co-localize with the signals of Sup35NMGFP and Rnq1GFP in nonprion cells, respectively (Fig. 6A-C) . Though colocalization signals of N-mCherry to Sup35NMGFP and Rnq1GFP were prevalent in non-prion cells, the extremely low spontaneous aggregation frequency (Fig.  5B) ] cells, respectively ( Fig. 6A and B) , whereas there were only about 8% and 16% of the total NmCherry ring/ribbon-like aggregates colocalized with Sup35NMGFP and Rnq1GFP in non-prion cells, respectively ( Fig. 6A and B ] cells, the initially formed Sup35-NMGFP and Rnq1GFP ring/ribbon-like aggregates were also mostly colocalizing with morphologically remodeled Swi1 aggregates as we previously reported . In non-prion cells, when Swi1N-mCherry was overproduced in the presence of 0.5% galactose, we found that Sup35-NMGFP and Rnq1GFP ribbon-like aggregates rarely colocalize with Swi1N-mCherry. In this case, only about 15% and 23% of the total ribbon-like aggregates of Sup35NMGFP and Rnq1GFP colocalized with Swi1N-mCherry, respectively (Fig. 6C ), suggesting that cross-seeding of Swi1 with Sup35 and/or Rnq1 rarely occurs in prionogenesis promoted merely by overproduction without a preexisting prion. Taken together, Sup35 and Rnq1 share similar interacting mechanistic features with Swi1 at their prion initiation stage.
Discussion
Based on our previous report that [SWI 1 ] tightly regulates the expression of FLO genes that are essential for yeast multicellularity (Du et al., 2015) , we have dissected the FLO11 promoter through a serial truncation analysis with the goals of understanding the FLO11 regulation by SWI/SNF and establishing a simple, faithful reporter system for [SWI 1 ] study. As shown in Figs 1 and 2, we identified several truncated variants of the FLO11 promoter that can report the prion status of Swi1. Interestingly, we also uncovered a strain-specific requirement of Flo8 on some of the truncated FLO11 promoter variants. A. The indicated 74D-694 strains were co-transformed with p423GAL1-NmCherry and pCUP1-NMGFP. The ring/ribbon-like Swi1N-mCherry aggregates (NmCh) that are supposed to be prionogenic in Swi1 prionogenesis were quantified for their interaction with Sup35-NMGFP (NMGFP) at low (low N-mCh, 0.02% galactose) or high (high N-mCh, 0.5% galactose) production of Swi1-PrD. Notably, 10 lM CuSO 4 was supplemented, and both co-localizing and non-co-localizing patterns were observed after 48 h induction. The images shown on the right are representatives and plots are a summary of data from at least three independent experiments. B. Similar to panel A, but the 74D-694 strains were co-transformed with p423GAL1-NmCherry and pCUP1-NMGFP, and the interaction is for Swi1 N-mCh and Rnq1-GFP. C. A [SWI 1 ] or a non-prion 74D-694 strain was co-transformed with p423GAL1-NmCherry and pCUP1-NMGFP, or with p423GAL1-NmCherry pCUP1-RNQ1GFP. Subsequently, the newly formed Sup35NMGFP (NMGFP) and Rnq1GFP ring/ribbon-like aggregates were assayed for colocalization with Swi1N-mCherry after 48 h of incubation. Low NmCh, 0.02% galactose; high NmCh, 0.5% galactose. In the experiment, 10 mM CuSO 4 was supplied as minimum to visualize Sup35NMGFP and Rnq1GFP aggregation. Here shows a summary of the colocalizing frequencies (left) and representative images of the co-localization (right). Statistical analysis in the figure was performed by T test (*, P < 0.05; **, P < 0.01; ***, P < 0.001). (Aigle and Lacroute, 1975; Wickner, 1994; Brachmann et al., 2006) , which can also be as high as 10 24 . Previously, the rate of spontaneous forma- ] prions are abundant cytoplasmic proteins with a PrD rich in both glutamine and asparagine. It seems our newly determined spontaneous formation rate of [SWI 1 ] is in agreement with an earlier prediction that PrDs with higher glutamine/asparagine ratios seem to give rise to higher numbers of seeds (i.e. aggregates that can act as a template for the prion form) but lower prion formation rates whereas PrDs with lower ratios may give lower seed numbers but higher prion formation rates . However, the rate of a prion may be variable under different conditions, such as, in the absence of [PIN 1 ], the [URE3] rate can be 10 fold lower (Bradley et al., 2002) . Further research is needed to verify above observations and test the accuracy of the prediction.
Establishing and analyzing a reliable [SWI
Molecular chaperones are usually proteins that assist folding of nascent proteins and/or unfolding of misfolded proteins. It has been shown that different prions can interact differently with molecular chaperones which are necessary for prion formation and propagation. For example, Hsp104 is needed for fragmentation of larger amyloid fibrils to produce prion seeds essential for prion propagation. Actually, Hsp104 overproduction can eliminate [PSI 1 ] but has no effect on other prions (Chernoff et al., 1995; Crow and Li, 2011) ] variants that can be cured by SSE1 deletion (Fan et al., 2007; Kryndushkin and Wickner, 2007; . In addition, [SWI 1 ] is uniquely sensitive to Sis1 overproduction and YDJ1 deletion . Intriguingly, variants of the same prion can also interact with molecular chaperones dramatically different. For instance, Sse1 is required for propagating a weak [PSI
1
] variant but not for the propagation of a stronger variant under identical experimental conditions (Fan et al., 2007; Kryndushkin and Wickner, 2007 ] variant in a S288C strain was not (Fig. 3B and  C) . Although it is possible that a different NEF other than Sse1, such as Sse2 or Fes1 (Mukai et al., 1993; Kabani et al., 2002) , is required for interacting with Hsp70-Ssa for [SWI 1 ] maintenance in the S288C strain, our observation that Sse1 is actively engaged in [SWI 1 ]
seed production in both strains of 74D-694 and S288C ( Fig. 3B-E) indicates that it is not the case. The mechanism that underlies this strain-specific interaction of [SWI
] and Sse1 remains to be investigated. Besides PrP Sc , amyloid architecture is shared by a large number of other pathogenic proteins, including asynuclein, b-amyloid, tau and TDP-43, each of which is tightly linked to a fatal, devastating neurodegenerative disease (Soto, 2003; Aguzzi and O'Connor, 2010; Eisenberg and Jucker, 2012) . As yeast prions are naturally occurring heritable amyloids, the budding yeast becomes a powerful model organism to study the behavior of amyloids. Although it is known that amyloidogenesis generally initiates from aberrant protein folding and aggregation, molecular events leading to amyloidosis remain poorly understood. In this study, we observed that in both cases of spontaneous [SWI and a group of potential glutamine/asparagine-rich prion candidates when overproduced (Zhou et al., 2001; Alberti et al., 2009; . In the case of [PSI 1 ] de novo formation, although both ring/ribbon-like and dot-like aggregation may appear upon Sup35 overproduction, only the former is usually prionogenic Zhou et al., 2001; Alberti et al., 2009) . In this study, we also observed that higher [SWI 1 ] formation rates are associated with higher rates of ring/ribbon-like Swi1 aggregation (Fig. 4B , 5B and 5C). The fact that both ring/ribbon-like and dot-like aggregates of [PSI 1 ] share the same bundled fibrillar amyloid structure (Kawai-Noma et al., 2010; Tyedmers et al., 2010) suggests that this morphologic change of aggregation from ribbon-like to dot-like is unlikely to involve any significant changes in prion amyloid structures rather being a result of changes in their association partners.
We ] formation rate 21.5x higher than that of the non-prion strain (Fig. 5A and C) ]. We also demonstrate here that a larger fraction of Swi1 aggregates are ring/ribbon-like in the nonoverproduction condition than observed in N-mCherry overproduction conditions (compare Fig. 5B and C) , indicating that Swi1PrD overproduction resulted in producing more non-prionogenic, off-pathway aggregation products.
Previous studies suggest that interactions of heterologous prion proteins mainly happen during the early phase of the prionogenesis process of [PSI 1 ] and [PIN 1 ] (Bagriantsev and Liebman, 2004; Derkatch et al., 2004; . This is further confirmed by our finding that colocalization of Swi1 with Rnq1 or Sup35 mainly takes place at the initial prionogenic stage of [SWI
] formation (Fig. 4C, 6A and 6B). We also show that with or without overproduction, the initially formed ring/ribbon-like aggregates of Swi1, Sup35 and Rnq1 predominantly overlap with the pre-existing prion facilitator even though some non-colocalizing aggregation can also occur simultaneously. In a non-prion strain, such a cross-seeding mechanism can also be prevalent without an overproduction event, but it rarely occurs when a prion protein is overproduced. conversion promoted by the preexisting prion. These results suggest that the cross-seeding mechanism of using a pre-existing prion(s) as a template is an efficient means to facilitate the formation of another prion. The mechanistic events of yeast prion formation and interaction described here may have implications on etiologies of mammalian amyloidosis, which is also caused by protein misfolding and aggregation, similar to that of yeast prions (Chiti and Dobson, 2006; Prusiner, 2012; Soto, 2012) . Many of these pathogenic proteins contain a glutamine/asparagine-rich prion-like region (King et al., 2012) . Notably, some of these pathogenic proteins often can co-aggregate (Gotz et al., 2001; Ono et al., 2012; Guo et al., 2013) . It remains of great interest to understand how cross-seeding and other interaction mechanisms function in the aggregation and co-aggregation events of these pathogenic proteins. Thus the study of yeast prions can provide insights into our understanding of the general mechanisms involved in protein misfolding, aggregation and protein misfolding diseases.
Experimental procedures
Oligonucleotides, plasmids and yeast strains that were used in this study are shown in Supporting Information Table S1 , S2 and S3 respectively.
Plasmid construction
Plasmids of p413TEF-NYFP, p413TEF-NQYFP, p413GAL1-NYFP, p413GAL1-NQYFP, p423GAL1-NYFP, p423GAL1-NQYFP, p423GPD-NYFP, p425GPD-NQYFP, p425GPD-NYFP and p425GPD-SWI1YFP were constructed by subcloning the corresponding N-YFP, NQ-YFP and SWI1-YFP fragment from p416TEF-NYFP, p416TEF-NQYFP and p416TEF-SWI1-YFP into empty vectors of p413TEF, p413GAL1, p423GAL1, p423GPD and p425GPD through sites of SpeI/XhoI, respectively. A 714-bp mCherry PCR product was amplified with primer pair of mCherry-F/ mCherry-R using p413TEF-SWI1mCherry as a template, and the PCR product was used to replace the YFP fragment of p413TEF-NYFP and p413TEF-NQYFP after digestion with XmaI and XhoI, generating p413TEF-NmCherry and p413TEF-NQmCherry, respectively. Further, NmCherry and NQmCherry from p413TEF-NmCherry and p413TEF-NQmCherry were sub-cloned into p423GAL1 through SpeI/ XhoI sites, resulting in p423GAL1-NmCherry and p423GAL1-NQmCherry, respectively. FLO11 promoter (P FLO11 ) was PCR-amplified with primer pair of FLO11S-F/1-3R from template DNA extracted from LY746. To dissect the FLO11 promoter, P F13 and P F16 were also PCR-amplified from LY746 genomic DNA using primer pairs of 1-3F/1-3R and 6F/1-3R, respectively. P F136 was generated by an overlapping PCR (bridge-PCR) -the primary PCR was done with primer pair of 6F/6R (with a 30-bp 3' extension homologous to the 5' sequence of P F13 , PCR 6) using the FLO11 promoter PCR product as a template; and the secondary PCR was conducted with primer pair of 6F/1-3R using a mixture of PCR 6 and P F13 as template. P F1369 PCR product was also acquired by Establishing and analyzing a reliable [SWI 1 ] reporter 119 bridge-PCR -PCR was first performed with primer pair of 9-10F/9-10R2 (with a 30-bp 3' extension homologous to the 5' sequence of PCR 6, PCR 9-10) using the FLO11 promoter PCR product as a template followed by another round PCR that was carried out with primer pair of 9-10F/1-3R using PCR 9-10 and P F136 as templates. Similarly, PCR was done with a pair of primers, 9-10F/9-10R1 (with a 30-bp 3' extension homologous to the 5' sequence of P F13, PCR 9-10a) using the full-length FLO11 promoter PCR product as a template. Further, PCR using the primer pair of 9-10F/1-3R and PCR 9-10a and P F13 as templates created P F139 . The obtained PCR products of P FLO11 , P F13 , P F16 , P F136 , P F139 , P F1369 were then digested with XmaI and SacII, and used to replace the SUC2-LEU2 promoter in p415SL-URA3, leading to plasmids of p415FLO11-URA3, p415F13-URA3, p415F16-URA3, p415F136-URA3, p415F139-URA3 and p415F1369-URA3, respectively. Moreover, ADH2 and HO promoters were PCR-amplified with primer pairs of ADH2-F/ADH2-R and HO-F/HO-R using the chromosomal DNA of YJW 426 as PCR template followed by another round of PCR using the first PCR products as templates, and the primer pairs of ADH2S-F/ ADH2X-R and HOS-F/HOX-R. The resulting PCR products were then digested with XmaI and SacII, and used to replace the SUC2-LEU2 promoter in p415SL-URA3 to generate p415ADH2-URA3 and p415HO-URA3, respectively. Plasmid p425GPD-SSE1 was constructed by sub-cloning SSE1 from p426GPD-SSE1 into p425GPD at the XhoI and SpeI sites. All the newly created plasmids were confirmed by restriction digestion and DNA sequencing.
Yeast strain engineering and cultivation DY902 was acquired by growing LY746 on media containing 5 mM GdnHCl to cure [PIN 1 ]. A successful curing was verified by lack of Rnq1-GFP aggregation upon transformation of the plasmid pCUP1-RNQ1GFP. Plasmid pCUP1-RNQ1GFP was then removed by counter selection on media containing 5-FOA. To replace the endogenous P FLO11 -FLO11 with P F139 -URA3, P F139 -URA3 fragment was firstly PCR-amplified with primers of Flo11ex-F and Flo11URA3-R using p415F139-URA3 as template. The acquired PCR product was used as template for a secondary PCR with primer pair of Flo11ex-F/Flo11ex-R. The generated PCR product was then used to transform DY902, a wild-type non-prion BY4741 strain. The obtained Ura 1 isolates are potential gene replacement mutants which are further verified by PCR with primers of Flo11ex-F and Flo11ex-R, leading to BY4741 flo8 flo11D:: P F139 -URA3 (DY767). DY767 was repaired for FLO8 gene by introducing SalI-digested pRS303-FLO8 into the strain to create the strain DY759. A successful FLO8 repair was indicated by a phenotypic switch from Adh -(adhesion negative) His -Ura (Park et al., 2006; Fan et al., 2007) . LB, YPD and SC (complete synthetic) media with certain amino acids dropout were used in this study otherwise specified. SC 1 5-FOA is a SC medium containing 0.1% 5-FOA, pH4.0. SC 1 raffinose 1 antimycin A has been previously described (Du et al., 2008) . In galactose induction experiments, 2% sucrose was used as the carbon source. To induce the expression of a CUP1 promoter-controlled Sup35 NMGFP or Rnq1-GFP for examining their prion states, 50 mM CuSO 4 was usually supplemented into a medium otherwise 10 mM CuSO 4 was used to study the interaction of Sup35, Rnq1 and Rnq1 at their prion initiation stage. For Escherichia coli cultures, 100 mg/ml ampicillin, or 30 mg/ml kanamycin was typically supplemented.
[SWI
] transfer and PCR experiments
A protein extract transformation-based protocol for [SWI 1 ] transfer was described previously (Du et al., 2010) with minimal modifications (Tanaka and Weissman, 2006 that were curable by 5 mM GdnHCl. In this study, PrimeSTAR HS DNA Polymerase (TaKaRa) was used in PCR to amplify DNA for cloning purposes. To extract DNA from yeast cells for PCR, yeast cells from cultures or colonies were simply boiled for 10 min in 20 mM NaOH, briefly cleared by centrifugation at 600 g for 2 min, and the crude supernatants used as PCR templates.
Adhesive growth and flocculation assays
Adhesive growth on SC plates was performed as described previously (Roberts and Fink, 1994; Braus et al., 2003; Du et al., 2010; Fichtner et al., 2007) with minor modifications. In brief, fresh cells were streaked or spread on proper SC selective plates, incubated for 3 days at 30 8 C and shifted to room temperature for additional 3 days before performing the washing assay. The washing assay was performed in a water bowl by swirling the plate for different times before taking images. A vigorous wash was done using tap water with or without rubbing.
Flocculation assay was carried our similarly to that reported before (Kobayashi et al., 1996) . Basically, after 2-3 days of growth in SC media, flocculating ability of cells was assessed based on appearance of visible cell aggregates. Saturated cell cultures were vigorously vortexed and images were taken as controls. Then images were taken in a time course to see appearance of cell pellets at the bottom of the tubes.
Fluorescence microscopy assays
In this study, GFP, YFP, CFP and mCherry serve as fluorescence tags for various fusion proteins. These fluorescent proteins were either expressed ectopically from a plasmid or endogenously from a chromosomal tag. Methods for fluorescence microscopy were described previously. For a constitutive promoter-driven expression, fresh colonies or log-phase cultures were used for microscopic observations. With an inducible promoter such as CUP1 or GAL1, CuSO 4 or galactose was added in log-phase cultures to induce the expression of a fluorescent protein. In this study, a concentration gradient was tested in a time course for both kinds of inducers to determine their minimal concentrations in liquid media and/or on solid plates. For instance, 10 mM CuSO 4 was used as a minimal concentration for Sup35 NM-GFP and Rnq1-GFP expression to ensure visibility of their aggregation in [PSI 1 ] and [PIN 1 ] cells but to avoid unnecessary overproduction of the protein, respectively. Similarly, 0.02% of galactose in a sucrose-based medium was used as minimum to detect Swi1 aggregation in cells without unnecessary overproduction for GAL1 promoter.
Assays for [SWI 1 ] propagation and stability impacted by chaperone activities A 74D-694 strain (LY722) or a BY4741 [SWI 1 ] strain (LY742) was co-transformed with p415F139-URA3 and p423GPD-SSE1 or p2HGHSP104 to overproduce Sse1 or Hsp104, or p423GPD as an empty vector control. Transformants were grown for 24, 48 or 72 h in liquid culture then spread onto SC selective plates. Colonies were then replica-plated onto SC, SC 1 5-FOA and SC-uracil to test the status of [SWI 1 ]; and their prion state was further verified by assaying their raffinose-ultilyzing ability and aggregation of Swi1NQYFP. Curing frequencies were normalized by total colony numbers obtained on SC plates. To see the effect of Hsp104 functional knock down by GdnHCl, the vector-transformed prion strains (with p415F139-URA3) were cultured in SC 1 5 mM GdnHCl medium in parallel before spreading and replica-plating experiments as described above. Swi1N-YFP aggregation was also assayed for randomly picked colonies from SC plates after the phenotypic curing tests upon removing the reporter plasmid and reintroducing p416TEF-NYFP. Similar assays were performed with another BY4741 strain (LY735) carrying chromosomal reporter of P FLO1 -URA3. In addition, to see how overproduction of Sse1 or Hsp104 affects [SWI 1 ]-curing by GdnHCl, LY735 carrying p425GPD-SSE1, p425GPD-HSP104, or p425GPD was cultured for 24, 48 and 72 h in 5 mM GdnHCl-containing SC selective medium, and assayed for stability of [SWI 1 ] similarly.
] de novo formation assays
To assay spontaneous [SWI 1 ] conversion frequency in BY4741 cells, a non-prion flo8::FLO8::HIS3 flo1::P FLo1 -URA3 strain (LY735) was cultured overnight in liquid YPD until reaching the stationary phase and spread onto SC-his and SC-his 1 5-FOA plates after proper dilution. Colonies that appeared on the 5-FOA plates were treated at least twice on SC-his 1 5 mM GdnHCl before replica-plating back to SC-his plates without uracil and SC-his 1 5-FOA plates to check their curability. Curable isolates were then transformed with p415TEF-NQYFP for aggregation assay to confirm ] and non-prion strains carrying the reporter plasmid p415F139-URA3 and p413GAL1-NQYFP were cultured in SC-leu for 2 days until the stationary phase before spreading onto SC-leu and SC-leu 1 5-FOA plates after proper dilution. Colonies that appeared on 5-FOA plates were replica-plated twice onto the same plates to stabilize the prion conformations before replica-plating onto SC-leu-his sucrose plates supplemented with 0.02% galactose to verify the presence of [SWI 1 ] prion by NQYFP aggregation assay. Isolates with at least more than 30% cells containing NQYFP aggregates were further colonypurified and assayed again. Eventually, isolates with at least 60% of cells containing NQYFP aggregation were scored as [SWI 1 ] isolates. To assay Swi1-PrD-promoted [SWI 1 ] formation, 74D-694 strains with different prion backgrounds Swi1N-YFP were co-transformed with p423GAL1-NYFP and p415F139-URA3. Sucrose-based log-phase cultures were then supplemented with or without 0.5% galactose and induced for 24 h before spreading onto SC-leu-his and SC-leu-his 1 5-FOA plates. 5-FOA 1 isolates were then tested for the aggregation of N-YFP on 0.02% galactose sucrose plates to verify their prion status as aforementioned. Aggregation and prion phenotypes were then verified by their curability by GdnHCl. In all these experiments, [SWI 1 ] rates were normalized with the total cells achieved on SC plates.
